TheraBiogen, Inc. Social Media Campaign

NEW YORK, Dec. 23, 2011 /PRNewswire/ -- TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, announced today the launch of its Social Media campaign as part of its ongoing product marketing program.

TheraBiogen is launching its social media campaign by utilizing mobile location based marketing, inclusive of Facebook, Foursquare, and YouTube in conjunction with its Times Square advertisement.

On December 28 and 29, 2011, visitors to Times Square will be encouraged to "check in" at the TheraMax® ad (located directly under the famous CBS Eye on 42nd Street) using Facebook Places or Foursquare and share their "Check In" online. A TheraMax® Street Team will be on location handing out samples of Thera Max® Cold & Flu, as well as other holiday gifts, to participants. (While supplies last).

Kelly Hickel, CEO of TheraBiogen, commented, "We are very enthusiastic about this latest portion of our marketing campaign and are thrilled to observe the responses from the people in Times Square and on our social media sites."

TheraMax® Cold and Flu is an all-natural, non-zinc, non-addictive, over-the-counter cold and flu relief agent. Over 50 million Americans contract the flu each year and consumer demand for a homeopathic, non-zinc remedy is a 2.5 billion dollar market according to research studies.

TheraMax® is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets as well as two of the three largest retailers. For more information on TheraMax® visit our website at www.theramaxrelief.com, our Facebook page at facebook.com/theramaxnasalspray or follow us on Twitter at http://twitter.com/TheraMaxRelief.

About TheraBiogen, Inc.
TheraBiogen is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit www.theramaxrelief.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.

Company Contact:

Public Relations Contact:

Investor Contact:

TheraBiogen, Inc.

Megan Megale

Boutcher & Boutcher

Kelly T. Hickel, CEO

Megale Public Relations

Aimee Boutcher

732-294-8705

703-625-8093

973-239-2878

kthickel@therabiogen.com

mmegale@megalepr.com

Aboutcher@therabiogen.com

SOURCE TheraBiogen, Inc.

Back to news